Among the upregulated genes, S100A8 and S100A9 were associated with poor prognosis in patients with ESCC and enhanced the migration and invasion abilities of ESCC cells via the Akt and p38 MAPK signaling pathways [20]. The gene discussed is S100A9; the disease is esophageal squamous cell carcinoma.